Home > Boards > US Listed > Biotechs > KemPharm Inc. (KMPH)

Most ppl on another mb, think KMPH will

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
gi197845 Member Profile
 
Followed By 4
Posts 2,659
Boards Moderated 1
Alias Born 08/16/16
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/29/2021 4:11:46 PM
KemPharm to Present at the Benzinga Healthcare Small Cap Conference GlobeNewswire Inc. - 9/27/2021 7:30:00 AM
KemPharm to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference GlobeNewswire Inc. - 9/23/2021 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/20/2021 5:03:46 PM
KemPharm to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference GlobeNewswire Inc. - 9/9/2021 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/1/2021 4:04:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/30/2021 5:10:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/24/2021 4:52:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/24/2021 4:49:40 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/24/2021 4:28:14 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/24/2021 4:27:00 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 8/20/2021 5:05:31 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/18/2021 5:38:51 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/18/2021 5:02:31 PM
KemPharm Appoints Tamara A. Seymour to Board of Directors GlobeNewswire Inc. - 8/18/2021 4:45:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2021 5:02:50 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 8/13/2021 7:40:21 AM
KemPharm Reports Second Quarter 2021 Financial Results GlobeNewswire Inc. - 8/12/2021 4:05:00 PM
KemPharm to Report Second Quarter 2021 Results GlobeNewswire Inc. - 8/5/2021 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/21/2021 8:46:55 AM
KemPharm Announces U.S. Launch of Innovative ADHD Treatment AZSTARYS™ (serdexmethylphenidate and dexmethylphenidate capsule... GlobeNewswire Inc. - 7/21/2021 8:30:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 7/12/2021 4:18:49 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 7/7/2021 4:51:06 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 7/2/2021 4:32:30 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/2/2021 4:02:36 PM
gi197845   Wednesday, 08/11/21 12:43:18 PM
Re: doebop post# 756
Post # of 771 
Most ppl on another mb, think KMPH will continue with dilution and shelf offerings, not that they are needed, but because the CEO and his wife want the cash and prizes, which are being used to finance their lavish lifestyles.

You are the only one I know that has not caught onto this.

Expect after the Q3 call for the share price to go down, within a day or two.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences